Spruce Biosciences, Inc. Common Stock

€43.32
EUR
Last updated on --.
24h volume19.04K
24h highest45.7659 EUR
24h lowest43.2759 EUR
24h Price movement-2.78%

SPRB recent prices

24 Hours
-2.78%-€1.239
30 days
-4.63%-€2.181
60 days
-10.76%-€5.415
90 days
-4.92%-€2.327

Key data

Previous close44.5618 EUR
Market cap121.95M EUR
Volume19.04K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-11.6200 EUR
Net income (FY)-31.99M EUR
Revenue (FY)--
Last report date13 May 2026

About Spruce Biosciences, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
HeadquartersSOUTH SAN FRANCISCO
Employees (FY)8.00
Net income per employee (FY)-4.00M EUR
Listed onNasdaq
Official website

SPRB conversion tables

SPRBSPRB
EUREUR
0.5 SPRB21.66 EUR
1 SPRB43.32 EUR
5 SPRB216.63 EUR
10 SPRB433.26 EUR
EUREUR
SPRBSPRB
0.5 EUR0.01154 SPRB
1 EUR0.02308 SPRB
5 EUR0.1154 SPRB
10 EUR0.2308 SPRB

FAQ

SPRB is trading at €43.32, -2.78% over the last 24 hours. Track live moves on the price chart at the top of this page.
The SPRB stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. SPRB is currently trading at €43.32, -2.78% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on SPRB price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. SPRB's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from SPRB; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against SPRB's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Spruce Biosciences, Inc. Common Stock's market cap is currently 121.95M EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume19.04K
24h highest45.7659 EUR
24h lowest43.2759 EUR
24h Price movement-2.78%
SPRBSPRB
EUREUR
Start trade with SPRB Perpetual